<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
12714-906-05
</NDCCode>
<PackageDescription>
40000000 mg in 1 CONTAINER (12714-906-05)
</PackageDescription>
<NDC11Code>
12714-0906-05
</NDC11Code>
<ProductNDC>
12714-906
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Synjardy
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20140912
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Boehringer Ingelheim Pharma GmbH and Co. KG
</LabelerName>
<SubstanceName>
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
12.5; 1000
</StrengthNumber>
<StrengthUnit>
mg/1000mg; mg/1000mg
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2025-01-24
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
12-SEP-14
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>